Zenflow raises $31M

A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Series A financing round to further its minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate.

The condition affects half of all men between the ages of 51 and 60, and up to 90 percent of men greater than 80 years of age. It occurs when the prostate gland becomes enlarged (but not cancerous) and encroaches on the urinary tract.

Zenflow’s solution is a device to prop open the urethra, thereby mitigating the symptoms of BPH without the need for surgery or medications. Dubbed the Spring System, it was designed by a team of Stanford Biodesign Innovation Fellows, including Nick Damiano and Shreya Mehta who went on to found the company in 2014.

Read the full story at MedCity News